Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid for Early Syphilis Treatment
NCT05548426Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Sep 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of linezolid in syphilis (2 arms), sponsored by University of Southern California. Primary endpoint: Response to Treatment at 6 months. Started Sep 2023; status: completed.
02
Drugs
linezolid
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT05548426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05548426.